GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Inventory Turnover

Fisher & Paykel Healthcare (NZSE:FPH) Inventory Turnover : 0.88 (As of Sep. 2023)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Fisher & Paykel Healthcare's Cost of Goods Sold for the six months ended in Sep. 2023 was NZ$318 Mil. Fisher & Paykel Healthcare's Average Total Inventories for the quarter that ended in Sep. 2023 was NZ$363 Mil. Fisher & Paykel Healthcare's Inventory Turnover for the quarter that ended in Sep. 2023 was 0.88.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Fisher & Paykel Healthcare's Days Inventory for the six months ended in Sep. 2023 was 208.56.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Fisher & Paykel Healthcare's Inventory-to-Revenue for the quarter that ended in Sep. 2023 was 0.44.


Fisher & Paykel Healthcare Inventory Turnover Historical Data

The historical data trend for Fisher & Paykel Healthcare's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Inventory Turnover Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.71 3.03 3.48 2.00 1.77

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.18 0.91 0.73 0.96 0.88

Fisher & Paykel Healthcare Inventory Turnover Calculation

Fisher & Paykel Healthcare's Inventory Turnover for the fiscal year that ended in Mar. 2023 is calculated as

Inventory Turnover (A: Mar. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Mar. 2023 ) / ((Total Inventories (A: Mar. 2022 ) + Total Inventories (A: Mar. 2023 )) / count )
=642.7 / ((358.9 + 365.8) / 2 )
=642.7 / 362.35
=1.77

Fisher & Paykel Healthcare's Inventory Turnover for the quarter that ended in Sep. 2023 is calculated as

Inventory Turnover (Q: Sep. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Sep. 2023 ) / ((Total Inventories (Q: Mar. 2023 ) + Total Inventories (Q: Sep. 2023 )) / count )
=317.6 / ((365.8 + 360.1) / 2 )
=317.6 / 362.95
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fisher & Paykel Healthcare  (NZSE:FPH) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Fisher & Paykel Healthcare's Days Inventory for the six months ended in Sep. 2023 is calculated as:

Days Inventory =Average Total Inventories (Q: Sep. 2023 )/Cost of Goods Sold (Q: Sep. 2023 )*Days in Period
=362.95/317.6*365 / 2
=208.56

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Fisher & Paykel Healthcare's Inventory to Revenue for the quarter that ended in Sep. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=362.95 / 815.8
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Fisher & Paykel Healthcare Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.